Navigation Links
Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
Date:5/21/2012

lete its review of the lorcaserin NDA resubmission by the PDUFA date; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to lorcaserin and Arena's other research and development programs may not meet safety, efficacy or other regulatory requirements or otherwise be sufficient for regulatory review or approval; even if any of Arena's drug candidates is approved for marketing, such approval may be subject to limitations on the indicated uses, restricted distribution methods and other limitations; risks related to commercializing new products; unexpected or unfavorable new data; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the SEC, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 and its Current Report on Form 8-K filed with the SEC on May 15, 2012. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... April 24, 2015 In today,s ever-changing ... groups around the world to access diverse skill ... While there are many areas to misstep in ... which best practices are necessary and beneficial in ... According to research by benchmarking firm, Best ...
(Date:4/24/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is scheduled ... Healthcare Conference on May 6 in Boston ... and chief financial officer, and Susie Lisa , vice ... answer session regarding the company with the host analyst at ... the presentation and question and answer session will be available ...
(Date:4/24/2015)... , April 24, 2015 ... portfolio of automated, indication-specific planning tools for radiosurgery/SBRT ... focused software applications aimed at enhancing the workflow ... and spine introduced in 2013 - comes full ... (SRS) planning tools. These new Elements enable on-the-fly ...
Breaking Medicine Technology:Work Around the Clock: Building Effective Global Capabilities 2Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2
... March 1, 2011 Developed by inventor John Vito and represented ... in this lot disclose an advanced medical inhaler design that is ... (Logo:   http://photos.prnewswire.com/prnh/20100614/CG20517LOGO ) The patents will ... IP Auction on March 31, 2011 in New York City. ...
... may not be enough to impact the productivity of ... and coronary artery disease.  That key finding and others ... Alere Health and other industry experts at the Integrated ... (NBCH) Conference in San Francisco, Tuesday, March 1. ...
Cached Medicine Technology:An Easier Way to Breathe Better - ICAP Ocean Tomo Announces an Advanced Medical Inhaler Design 2Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference 2Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference 3
(Date:4/27/2015)... Cannabix Technologies Inc. (CSE: BLO) (OTC ... Iannapollo has become an Advisor to Cannabix Technologies, developer ... and workplace testing. Mr. Iannapollo is an expert on ... experience in the oil and gas industry, working for ... employer, and DOT compliance policies and strategies. He also ...
(Date:4/27/2015)... The global coagulation analyzers market is estimated to ... however, it is expected to witness high growth ... Brazil in the next five years. Growth in ... such as increasing adoption of automated hemostasis instruments ... developments in high-sensitivity point-of-care coagulation analyzers and introduction ...
(Date:4/27/2015)... The Global Pharmaceutical Packaging Market 2015 – ... 5.9% during the period 2015 – 2019. Plastics will ... packaging market, mainly due to their cost effectiveness and ... is extremely fragmented with the presence of several global ... market with the rest being occupied by several international ...
(Date:4/27/2015)... April 27, 2015 On the top ... dramatic nighttime skyline of beautiful Los Angeles, CA, Per ... star of “The Real Housewives of Orange County” Gretchen ... Entertainment’s EcoLuxe Lounge and the “Salute to the Oscars” ... for substance abuse founded by Wickstrom, Rossi felt that ...
(Date:4/27/2015)... The Sanford J. Grossman Charitable Trust, founded ... has committed $3 million to establish the Dr. Sanford ... Disease at the Icahn School of Medicine at Mount ... for treatment of Crohn’s disease, with the overarching goal ... a chronic inflammatory disorder of the bowel first described ...
Breaking Medicine News(10 mins):Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4Health News:Per Wickstrom Shares His Vision of Choices Recovery with Reality TV Star Gretchen Christine Rossi 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 3
... more benefit, experts say , TUESDAY, April 6 (HealthDay News) ... pain has exploded in the past six years, even ... treatments and not necessarily more effective, a study finds. , ... big the increase was," said Dr. Richard A. Deyo, professor ...
... proportion of older middle-aged Americans who report disabilities related ... contrast to the disability decline that has been found ... new study by the RAND Corporation and the University ... proportion of Americans aged 50 to 64 who reported ...
... designed to reduce HIV/STDs previously used exclusively by academic ... an important component in national strategies to curtail the ... can be reached. , A new study by ... proven HIV/STD risk-reduction intervention would work when led by ...
... health information technology will support care between office visits, ... lives. An evaluation in the April Health Affairs ... new approach: Routinely ask patients how they like it ... ask patients whether the health information technology they use ...
... 6, 2010 The nation,s preterm birth rate dropped for the ... percent decline in the preterm birth rate, according to a report ... March of Dimes officials say they are encouraged and hope that ... are based on 99.9 percent of U.S. births and the improvement ...
... , ... Spiritual Politics and Builders of the Dawn reveals a new world growing all around us and ... ... state of our planet in 2010 may make some people want to go into hiding. But ...
Cached Medicine News:Health News:Complex Spinal Operations Soar Despite Drawbacks 2Health News:Complex Spinal Operations Soar Despite Drawbacks 3Health News:Middle-aged Americans report more mobility-related disabilities 2Health News:Middle-aged Americans report more mobility-related disabilities 3Health News:Roll-out of proven HIV/STD risk-reduction intervention with teens by community groups successful 2Health News:Want better health information technology? Ask patients how they want it 2Health News:Preterm birth rate drops 3 percent 2Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 2Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 3Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 4Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 5
... Mouthpiece 7FT O 2 Tubing Tee Adapter, ... for fast treatment times , ... (higher percentage of respirable particles) than conventional nebulizers, ... Max 10™ disposable nebulizers deliver fast and effective ...
Nebulizer Custom Kit...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: